BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 2541445)

  • 21. c-myc and c-myb oncoproteins during induced maturation of myeloid and erythroid human leukemic cell lines.
    Pedrazzoli P; Bains MA; Watson R; Fisher J; Hoy TG; Jacobs A
    Cancer Res; 1989 Dec; 49(24 Pt 1):6911-6. PubMed ID: 2684403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A DNA uptake-stimulating protein increases the antiproliferative effect of c-myb antisense oligonucleotide on leukemic cells.
    Tóth G; Schlammadinger J; Aradi J; Antal-Szalmás P; Sipka S; Balázs M; Kovács P; Fehér Z; Falus A
    Cell Biol Int; 2004; 28(11):817-23. PubMed ID: 15563404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the antisense v-myb' expression on K562 human leukemia cell proliferation and differentiation.
    Kamano H; Ohnishi H; Tanaka T; Ikeda K; Okabe A; Irino S
    Leuk Res; 1990; 14(10):831-9. PubMed ID: 1979645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging.
    Calabretta B; Sims RB; Valtieri M; Caracciolo D; Szczylik C; Venturelli D; Ratajczak M; Beran M; Gewirtz AM
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2351-5. PubMed ID: 2006173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Telomerase activity in human leukemic cell lines is inhibited by antisense pentadecadeoxynucleotides targeted against c-myc mRNA.
    Fujimoto K; Takahashi M
    Biochem Biophys Res Commun; 1997 Dec; 241(3):775-81. PubMed ID: 9434785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb.
    Melani C; Rivoltini L; Parmiani G; Calabretta B; Colombo MP
    Cancer Res; 1991 Jun; 51(11):2897-901. PubMed ID: 2032228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of proliferation by c-myb antisense RNA and oligodeoxynucleotides in transformed neuroectodermal cell lines.
    Raschellà G; Negroni A; Skorski T; Pucci S; Nieborowska-Skorska M; Romeo A; Calabretta B
    Cancer Res; 1992 Aug; 52(15):4221-6. PubMed ID: 1638535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential binding of nuclear c-ets-1 protein to an intron I fragment of the c-myb gene in growth versus differentiation.
    Wang LG; Liu XM; Li ZR; Denstman S; Bloch A
    Cell Growth Differ; 1994 Nov; 5(11):1243-51. PubMed ID: 7848925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of cell proliferation: late down-regulation of c-myb preceding myelo-monocytic cell differentiation.
    Yen A; Samuel V; Forbes M
    J Cell Physiol; 1992 Oct; 153(1):147-56. PubMed ID: 1522128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissociation between p93B-myb and p75c-myb expression during the proliferation and differentiation of human myeloid cell lines.
    Arsura M; Luchetti MM; Erba E; Golay J; Rambaldi A; Introna M
    Blood; 1994 Apr; 83(7):1778-90. PubMed ID: 8142646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition by interleukin 4 of leukemia inhibitory factor-, interleukin 6-, and dexamethasone-induced differentiation of mouse myeloid leukemia cells: role of c-myc and junB proto-oncogenes.
    Kasukabe T; Okabe-Kado J; Hozumi M; Honma Y
    Cancer Res; 1994 Jan; 54(2):592-7. PubMed ID: 8275499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
    Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M
    Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15(INK4b) normally associated with differentiation.
    Schmidt M; Koller R; Haviernik P; Bies J; Maciag K; Wolff L
    Oncogene; 2001 Sep; 20(43):6205-14. PubMed ID: 11593429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of c-myc expression by antisense oligonucleotides inhibits proliferation of human smooth muscle cells.
    Shi Y; Hutchinson HG; Hall DJ; Zalewski A
    Circulation; 1993 Sep; 88(3):1190-5. PubMed ID: 8353880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Truncation of the c-myb gene by a retroviral integration in an interleukin 3-dependent myeloid leukemia cell line.
    Weinstein Y; Ihle JN; Lavu S; Reddy EP
    Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5010-4. PubMed ID: 3014527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of c-myc antisense oligodeoxynucleotide transfected by liposome on HL-60 cells].
    Chen L; Zhuo G; Chen Z
    Zhonghua Nei Ke Za Zhi; 2000 Oct; 39(10):660-3. PubMed ID: 11374170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Redundant functions of B-Myb and c-Myb in differentiating myeloid cells.
    Golay J; Broccoli V; Borleri GM; Erba E; Faretta M; Basilico L; Ying GG; Piccinini G; Shapiro LH; Lovrić J; Nawrath M; Mölling K; Rambaldi A; Introna M
    Cell Growth Differ; 1997 Dec; 8(12):1305-16. PubMed ID: 9419419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deregulated c-myb disrupts interleukin-6- or leukemia inhibitory factor-induced myeloid differentiation prior to c-myc: role in leukemogenesis.
    Selvakumaran M; Liebermann DA; Hoffman-Liebermann B
    Mol Cell Biol; 1992 Jun; 12(6):2493-500. PubMed ID: 1588953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of cisplatin and c-myb antisense phosphorothioate oligodeoxynucleotides combination on a human colon carcinoma cell line in vitro and in vivo.
    Del Bufalo D; Cucco C; Leonetti C; Citro G; D'Agnano I; Benassi M; Geiser T; Zon G; Calabretta B; Zupi G
    Br J Cancer; 1996 Aug; 74(3):387-93. PubMed ID: 8695353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DMSO-like rapid decrease in c-myc and c-myb mRNA levels and induction of differentiation in HL-60 cells by the anthracycline antitumor antibiotic aclarubicin.
    Stöcker U; Schaefer A; Marquardt H
    Leukemia; 1995 Jan; 9(1):146-54. PubMed ID: 7845009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.